Home / Intelligence / Webinars / Simplifying the Complex: Data and Operational Challenges in Incentive Compensation
Available On Demand
Siloed approaches and communication problems are common hurdles that leaders focused on Incentive Compensation (IC) in life sciences face. Complex and proliferating data streams are another. Join Susheel Sukhtankar, Partner & Head of Commercial Analytics, as he hosts panelists Cheryl Crawford, SVP of Data Management & Commercial Operations, Jim Castello, VP of Field Operations & Incentive Compensation and Ed Bach, Principal.
Key Webinar Topics
- Communicating seamlessly—alignment between leadership, home office and field teams
- Leveraging appropriate data—identification, evaluation and integration
- Proactive insights and analytics—timely reports and statements
Head of Commercial Analytics
Senior Vice President,
Data Management & Commercial Operations
Complete the form below to view the on-demand webinar.
What You Need to Know Now to Be Prepared for 2024
Highlights from TGaS Advisors’ Fall Summit How are Biopharmaceutical organizations evolving to develop capabilities and propel innovation for 2024 and beyond? Executive leaders in Commercial Operations, Medical Affairs and Market Access are focused on making informed decisions to propel the evolution of their organizations in this rapidly changing global economy. As you strategize to accelerate […]
The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?
In the pharmaceutical industry, there has been ongoing discussion whether the Commercial Operations departments should become a globalized function. Over the past decade as companies have become more global in commercializing their products, organizations have been investigating the effectiveness of the Commercial Operations ecosystem. For 20 years, TGaS Advisors, a Division of Trinity Life Sciences, […]
Leading the Evolution in Commercial Operations
This advisory brief incorporates learnings from TGaS Advisors’ 2023 Spring Summit, which brought together the industry’s top commercial operations, market access and medical affairs executives to discuss the hottest trends, address concerns and prepare for future challenges. Leaders from more than 100 emerging, mid tier and large tier biopharmaceutical companies attended function specific sessions. Leaders […]